Definium Therapeutics, Inc. (NASDAQ: DFTX) reported Q1 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Definium Therapeutics, Inc. (DFTX) click here.